drugset / Trial / NCT00625365

A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

NCT00625365

Phase 4 Completed 1060 enrolled Lantheus Medical Imaging
NaSingle-groupOpen-labelOther

Summary

The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®

Timeline

Start
2008-02
Primary completion
2009-05
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent Intravenous